Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Health Insurance Innovations Inc    HIIQ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Health Insurance Innovations, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2017 | 08:39pm CEST

Levi & Korsinsky announces it has commenced an investigation of Health Insurance Innovations, Inc. (“Health Insurance” or the “Company”) (NASDAQ:HIIQ) concerning possible violations of federal securities laws.

On September 11, 2017, an article was published on Seeking Alpha alleging, among other allegations, that: (1) in June 2017, one of the Company’s key license applications was rejected after regulators uncovered undisclosed legal actions against Company insiders; and (2) the Company privately warned a Florida regulator that a rejection of its license application could create a “domino effect” whereby licensing denials would spread to the other states. Following this news, shares of Health Insurance fell more than 18% to close at $23.35 per share on September 11, 2017. To obtain additional information, go to:

http://www.zlkdocs.com/HIIQ-Info-Request-Form-6098

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HEALTH INSURANCE INNOVATIO
09/18 THE KLEIN LAW FIRM : Reminds Investors of an Investigation Concerning Possible V..
09/18 Khang & Khang LLP Announces Securities Class Action Lawsuit against Health In..
09/16 HEALTH INSURANCE INNOVATIONS INC : Pomerantz Law Firm Reminds Shareholders with ..
09/16 HIIQ LOSS NOTICE : Rosen Law Firm Reminds Health Insurance Innovations, Inc. Inv..
09/16 HEALTH INSURANCE INNOVATIONS : RM LAW Announces Class Action Lawsuit Against Hea..
09/15 Lundin Law PC Announces Securities Class Action Lawsuit against Health Insura..
09/15 THE KLEIN LAW FIRM : Notifies Investors of an Investigation Concerning Possible ..
09/14 Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit aga..
09/14 HIIQ The Law Offices of Vincent Wong Reminds Investors of an Investigation In..
09/14 Health Insurance Innovations to Present at Cantor Fitzgerald Global Healthcar..
More news
News from SeekingAlpha
09/12 Midday Gainers / Losers
09/12 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
09/12 Lake Street says bearish SA article a "rehash" of old news, recommends aggres..
09/12 PREMARKET LOSERS AS OF 9 : 05 am
09/11 HEALTH INSURANCE INNOVATIONS TO HOST : 30 pm ET
Financials ($)
Sales 2017 230 M
EBIT 2017 34,5 M
Net income 2017 19,2 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 14,58
P/E ratio 2018 12,09
Capi. / Sales 2017 1,63x
Capi. / Sales 2018 1,41x
Capitalization 376 M
Chart HEALTH INSURANCE INNOVATIO
Duration : Period :
Health Insurance Innovatio Technical Analysis Chart | HIIQ | US42225K1060 | 4-Traders
Technical analysis trends HEALTH INSURANCE INNOVATIO
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 38,7 $
Spread / Average Target 69%
EPS Revisions
Managers
NameTitle
Gavin C. Southwell President & Chief Executive Officer
Paul G. Gabos Non-Executive Chairman
Michael D. Hershberger Chief Financial Officer, Secretary & Treasurer
Sheldon X. Wang Chief Technology Officer
Michael W. Kosloske Director & Chief-Product Innovation
Sector and Competitors